Toggle navigation
Home
Search
Services
Blog
Contact
About
PHASE II CLINIAL TRIAL OF NEW CHEMOPREVENTIVE AGENTS - WSn68 - ZILEUT-261005022
Wayne State University, Detroit, MI, United States
Search grants from Wayne State University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Role of MED1 in HER2-driven Breast Tumorigenesis
Molecular Mechanisms of EGF Signaling &Iressa/Tarceva Inhibition in NSCLC
Environmental Effects On Fertility
Applications for the National Information Infrastructure
Stone Risk Profile
Recently added grants:
Information and Dissemination in Support of Community Interventions
Hepatic stellate cell regulation of metastatic growth in the liver
Social Mechanisms of Early Alcohol and Substance Use Initiation and Progression to Problems
Automated in vivo analysis of tumor growth rate as a guide for therapeutic decisions to advance personalized cancer treatment
Mexican American Drinking Contexts On and Away from the U.S./Mexico Border
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN005022-001
Application #
6994809
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2004
Total Cost
Indirect Cost
Institution
Name
Wayne State University
Department
Type
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Related projects
NIH 2006
N01 CN
PHASE II CLINIAL TRIAL OF NEW CHEMOPREVENTIVE AGENTS - WSn68 - ZILEUT-261005022
/ Wayne State University
NIH 2004
N01 CN
PHASE II CLINIAL TRIAL OF NEW CHEMOPREVENTIVE AGENTS - WSn68 - ZILEUT-261005022
/ Wayne State University
NIH 2000
N01 CN
Phase II Clinial Trial of New Chemopreventive Agents - W
Kucuk, Omer / Wayne State University
$758,959
Comments
Be the first to comment on this grant